Streptococcus pneumoniae and chronic endobronchial infections in childhood

Kim Hare, Amanda Leach, Heidi Smith-Vaughan, Anne Chang, Keith Grimwood

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    Streptococcus pneumoniae (pneumococcus) is the main cause of bacterial pneumonia worldwide and has been studied extensively in this context. However, its role in chronic endobronchial infections and accompanying lower airway neutrophilic infiltration has received little attention. Severe and recurrent pneumonia are risk factors for chronic suppurative lung disease (CSLD) and bronchiectasis; the latter causes considerable morbidity and, in some populations, premature death in children and adults. Protracted bacterial bronchitis (PBB) is another chronic endobronchial infection associated with substantial morbidity. In some children, PBB may progress to bronchiectasis. Although nontypeable Haemophilus influenzae is the main pathogen in PBB, CSLD and bronchiectasis, pneumococci are isolated commonly from the lower airways of children with these diagnoses. Here we review what is known currently about pneumococci in PBB, CSLD and bronchiectasis, including the importance of pneumococcal nasopharyngeal colonization and how persistence in the lower airways may contribute to the pathogenesis of these chronic pulmonary disorders. Antibiotic treatments, particularly long-term azithromycin therapy, are discussed together with antibiotic resistance and the impact of pneumococcal conjugate vaccines. Important areas requiring further investigation are identified, including immune responses associated with pneumococcal lower airway infection, alone and in combination with other respiratory pathogens, and microarray serotyping to improve detection of carriage and infection by multiple serotypes. Genome wide association studies of pneumococci from the upper and lower airways will help identify virulence and resistance determinants, including potential therapeutic targets and vaccine antigens to treat and prevent endobronchial infections. Much work is needed, but the benefits will be substantial.

    Original languageEnglish
    Pages (from-to)1532-1545
    Number of pages14
    JournalPediatric Pulmonology
    Volume52
    Issue number12
    Early online date18 Sep 2017
    DOIs
    Publication statusPublished - Dec 2017

    Fingerprint

    Streptococcus pneumoniae
    Bronchiectasis
    Lung Diseases
    Infection
    Bronchitis
    Chronic Bronchitis
    Morbidity
    Bacterial Pneumonia
    Serotyping
    Conjugate Vaccines
    Pneumococcal Vaccines
    Azithromycin
    Premature Mortality
    Genome-Wide Association Study
    Haemophilus influenzae
    Microbial Drug Resistance
    Virulence
    Pneumonia
    Therapeutics
    Vaccines

    Cite this

    @article{05d18e84cb8c4f06b71d49ac72eea135,
    title = "Streptococcus pneumoniae and chronic endobronchial infections in childhood",
    abstract = "Streptococcus pneumoniae (pneumococcus) is the main cause of bacterial pneumonia worldwide and has been studied extensively in this context. However, its role in chronic endobronchial infections and accompanying lower airway neutrophilic infiltration has received little attention. Severe and recurrent pneumonia are risk factors for chronic suppurative lung disease (CSLD) and bronchiectasis; the latter causes considerable morbidity and, in some populations, premature death in children and adults. Protracted bacterial bronchitis (PBB) is another chronic endobronchial infection associated with substantial morbidity. In some children, PBB may progress to bronchiectasis. Although nontypeable Haemophilus influenzae is the main pathogen in PBB, CSLD and bronchiectasis, pneumococci are isolated commonly from the lower airways of children with these diagnoses. Here we review what is known currently about pneumococci in PBB, CSLD and bronchiectasis, including the importance of pneumococcal nasopharyngeal colonization and how persistence in the lower airways may contribute to the pathogenesis of these chronic pulmonary disorders. Antibiotic treatments, particularly long-term azithromycin therapy, are discussed together with antibiotic resistance and the impact of pneumococcal conjugate vaccines. Important areas requiring further investigation are identified, including immune responses associated with pneumococcal lower airway infection, alone and in combination with other respiratory pathogens, and microarray serotyping to improve detection of carriage and infection by multiple serotypes. Genome wide association studies of pneumococci from the upper and lower airways will help identify virulence and resistance determinants, including potential therapeutic targets and vaccine antigens to treat and prevent endobronchial infections. Much work is needed, but the benefits will be substantial.",
    keywords = "antibiotic therapy, bacterial bronchitis, bronchiectasis, nasopharyngeal colonization, pneumococcal vaccines",
    author = "Kim Hare and Amanda Leach and Heidi Smith-Vaughan and Anne Chang and Keith Grimwood",
    year = "2017",
    month = "12",
    doi = "10.1002/ppul.23828",
    language = "English",
    volume = "52",
    pages = "1532--1545",
    journal = "Pediatric Pulmonology",
    issn = "1099-0496",
    publisher = "John Wiley & Sons",
    number = "12",

    }

    Streptococcus pneumoniae and chronic endobronchial infections in childhood. / Hare, Kim; Leach, Amanda; Smith-Vaughan, Heidi; Chang, Anne; Grimwood, Keith.

    In: Pediatric Pulmonology, Vol. 52, No. 12, 12.2017, p. 1532-1545.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Streptococcus pneumoniae and chronic endobronchial infections in childhood

    AU - Hare, Kim

    AU - Leach, Amanda

    AU - Smith-Vaughan, Heidi

    AU - Chang, Anne

    AU - Grimwood, Keith

    PY - 2017/12

    Y1 - 2017/12

    N2 - Streptococcus pneumoniae (pneumococcus) is the main cause of bacterial pneumonia worldwide and has been studied extensively in this context. However, its role in chronic endobronchial infections and accompanying lower airway neutrophilic infiltration has received little attention. Severe and recurrent pneumonia are risk factors for chronic suppurative lung disease (CSLD) and bronchiectasis; the latter causes considerable morbidity and, in some populations, premature death in children and adults. Protracted bacterial bronchitis (PBB) is another chronic endobronchial infection associated with substantial morbidity. In some children, PBB may progress to bronchiectasis. Although nontypeable Haemophilus influenzae is the main pathogen in PBB, CSLD and bronchiectasis, pneumococci are isolated commonly from the lower airways of children with these diagnoses. Here we review what is known currently about pneumococci in PBB, CSLD and bronchiectasis, including the importance of pneumococcal nasopharyngeal colonization and how persistence in the lower airways may contribute to the pathogenesis of these chronic pulmonary disorders. Antibiotic treatments, particularly long-term azithromycin therapy, are discussed together with antibiotic resistance and the impact of pneumococcal conjugate vaccines. Important areas requiring further investigation are identified, including immune responses associated with pneumococcal lower airway infection, alone and in combination with other respiratory pathogens, and microarray serotyping to improve detection of carriage and infection by multiple serotypes. Genome wide association studies of pneumococci from the upper and lower airways will help identify virulence and resistance determinants, including potential therapeutic targets and vaccine antigens to treat and prevent endobronchial infections. Much work is needed, but the benefits will be substantial.

    AB - Streptococcus pneumoniae (pneumococcus) is the main cause of bacterial pneumonia worldwide and has been studied extensively in this context. However, its role in chronic endobronchial infections and accompanying lower airway neutrophilic infiltration has received little attention. Severe and recurrent pneumonia are risk factors for chronic suppurative lung disease (CSLD) and bronchiectasis; the latter causes considerable morbidity and, in some populations, premature death in children and adults. Protracted bacterial bronchitis (PBB) is another chronic endobronchial infection associated with substantial morbidity. In some children, PBB may progress to bronchiectasis. Although nontypeable Haemophilus influenzae is the main pathogen in PBB, CSLD and bronchiectasis, pneumococci are isolated commonly from the lower airways of children with these diagnoses. Here we review what is known currently about pneumococci in PBB, CSLD and bronchiectasis, including the importance of pneumococcal nasopharyngeal colonization and how persistence in the lower airways may contribute to the pathogenesis of these chronic pulmonary disorders. Antibiotic treatments, particularly long-term azithromycin therapy, are discussed together with antibiotic resistance and the impact of pneumococcal conjugate vaccines. Important areas requiring further investigation are identified, including immune responses associated with pneumococcal lower airway infection, alone and in combination with other respiratory pathogens, and microarray serotyping to improve detection of carriage and infection by multiple serotypes. Genome wide association studies of pneumococci from the upper and lower airways will help identify virulence and resistance determinants, including potential therapeutic targets and vaccine antigens to treat and prevent endobronchial infections. Much work is needed, but the benefits will be substantial.

    KW - antibiotic therapy

    KW - bacterial bronchitis

    KW - bronchiectasis

    KW - nasopharyngeal colonization

    KW - pneumococcal vaccines

    UR - http://www.scopus.com/inward/record.url?scp=85034604534&partnerID=8YFLogxK

    U2 - 10.1002/ppul.23828

    DO - 10.1002/ppul.23828

    M3 - Article

    VL - 52

    SP - 1532

    EP - 1545

    JO - Pediatric Pulmonology

    JF - Pediatric Pulmonology

    SN - 1099-0496

    IS - 12

    ER -